Screaming Buys: 2 Value Stocks That Increased Their Dividends

This pair of value stocks are screaming buys following their impressive quarterly results and dividend hikes.

| More on:
sale discount best price

Image source: Getty Images

This year has been tremendously upsetting for stock investors because market rallies are few and far between. Canada’s primary stock exchange has been shaky due to geopolitical tensions, supply chain disruptions, and inflationary pressures. Despite closing above 20,000 for the first time in more than two months on August 12, 2022, the TSX remains vulnerable.

However, during times of uncertainty, mediocre stocks take the back seat while quality stocks emerge. If you’re after value-for-money, Exchange Income Corporation (TSX:EIF), or EIC, and Medical Facilities (TSX:DR) are screaming buys today. Both companies reported impressive financial results in Q2 2022 and announced dividend increases.

Solid revenue and earnings growth

EIC investors are more than satisfied with their stock’s 19.8% positive return year to date amid the uncertainties. Its CEO, Mike Pyle, said, “The work you do in the past defines your future. Throughout the pandemic EIC stayed true to its business model, maintaining a strong balance sheet, investing in its companies, acquiring companies that meet our criteria and empowering our people.”

The $2 billion company has two core business segments, namely Aerospace & Aviation and Manufacturing. In Q2 2022, EIC achieved several milestones. The $529 million revenue and $30 million in net earnings were both record highs in the quarter, up 64% and 82%, respectively, versus Q2 2021.

Also, during the quarter, management increased its dividend (second consecutive quarter) by $0.12 per annum to $2.52. If you invest today ($48.93 per share), the dividend yield is a hefty 4.9%.

A cut above the rest  

Medical Facilities is a cut above the rest, considering that health care (-47.9%) is the worst-performing sector as of Friday last week. This health care stock is actually outperforming the broader market, up 11.5% versus a decline of -4.9% for the TSX year to date. Also, at $10.25 per share, the dividend yield is a decent 3.14%.

The $331.7 million company operates in the United States and owns a diverse portfolio of high-rated, high-quality surgical facilities. Currently, its controlling interests are in four specialty surgical hospitals and one ambulatory surgery centre. Moreover, the ownership stakes in five more ambulatory surgery centres are in partnership with NueHealth LLC.

Medical Facilities has a unique setup because the company partners with physicians who have a say in operations. In the first half of 2022, total revenue and other income increased by 4.5% to $196.3 million versus the same period in 2021. While net income in FH 2022 declined 4.7% year over year, net income in Q2 2022 versus Q2 2021 jumped 87.6% to US$22.2 million.

Robert O. Horrar, President and CEO of Medical Facilities, said, “Our surgical case volumes continued to improve in the quarter, particularly in the month of June, when volumes exceeded June 2021 volumes by 8.1% and June 2019, which was before the pandemic, by 8.9%.”

However, higher labor costs and other operating expenses had an impact on profitability. Still, Horrar assures that cash flow and the balance sheet remain strong. During the quarter, management raised its dividend by 3.7% (annualized yield).

Undervalued

Dividend-paying value stocks Exchange Income and Medical Facilities deserve serious consideration. Despite the outperformance, the share prices aren’t commensurate with their intrinsic or real values.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Dividend Stocks

money cash dividends
Dividend Stocks

Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

Want some absurdly cheap stocks for your portfolio? Here are two options trading at a huge discount right now.

Read more »

Gas pipelines
Dividend Stocks

TFSA Passive Income: Is Enbridge Stock a Buy, Sell, or Hold?

Enbridge now offers a yield near 8%. Is the dividend safe?

Read more »

clock time
Dividend Stocks

1 Growth Stock Down 28% to Buy Right Now

After being temporarily impacted by the economy in 2023, this growth stock is now ultra-cheap, making it one of the…

Read more »

sale discount best price
Dividend Stocks

3 Stocks to Buy While They Are on Sale

Top TSX dividend stocks are trading at discounted prices.

Read more »

Volatile market, stock volatility
Dividend Stocks

1 Dividend Stock Down 31% to Buy Right Now

Buying the dip has its advantages – lower downside risk and higher probability of growth. In a dividend stock, you…

Read more »

warning or alert
Dividend Stocks

Value Alert: Here’s Why TD Bank Stock Is an Excellent Buy Right Now

Toronto-Dominion Bank (TSX:TD) stock is too attractively priced for you to sleep on if you are interested in Canadian bank…

Read more »

Dividend Stocks

TFSA: The Best TSX Stocks to Invest $7,000 for February 2024?

These top TSX dividend stocks might be oversold right now.

Read more »

Oil pumps against sunset
Dividend Stocks

Should You Buy Cardinal Energy Stock for its 11% Dividend Yield?

Down 68% from all-time highs, Cardinal Energy stock offers a tasty dividend yield of 11% in 2024.

Read more »